{"id":1620,"date":"2021-10-15T20:39:00","date_gmt":"2021-10-15T20:39:00","guid":{"rendered":"https:\/\/www.prnasia.com\/story\/archive\/3541487_AE41487_0"},"modified":"2021-10-15T20:39:00","modified_gmt":"2021-10-15T20:39:00","slug":"novavax-to-participate-in-world-vaccine-congress-europe","status":"publish","type":"post","link":"https:\/\/transmediavictoria.net.au\/?p=1620","title":{"rendered":"Novavax to Participate in World Vaccine Congress Europe"},"content":{"rendered":"<div id=\"dvContent\" readability=\"67.732620320856\">\n<table name=\"logo_release\" border=\"0\" cellspacing=\"10\" cellpadding=\"5\" align=\"right\">\n<tbody>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mma.prnasia.com\/media2\/1506866\/Novavax_High_Res_Logo.jpg?p=medium600\" border=\"0\" alt title=\"logo\" hspace=\"0\" vspace=\"0\" width=\"118\"><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><span class=\"xn-location\">GAITHERSBURG, Md.<\/span>, <span class=\"xn-chron\">Oct. 16, 2021<\/span> \/PRNewswire\/ &#8212;&nbsp;Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that <span class=\"xn-person\">Vivek Shinde<\/span>, M.D., Vice President, Clinical Development, will deliver a presentation during the <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3325009-1&amp;h=1394430246&amp;u=https%3A%2F%2Fwww.terrapinn.com%2Fconference%2Fworld-vaccine-congress-europe%2Findex.stm&amp;a=World+Vaccine+Congress+Europe+2021\" rel=\"nofollow noopener\">World Vaccine Congress Europe 2021<\/a>. A topic of discussion will be Novavax&#8217; COVID-NanoFlu\u2122 Combination Vaccine, which combines the company&#8217;s recombinant nanoparticle&nbsp;protein-based COVID-19 and NanoFlu\u2122 vaccine candidates with Matrix-M\u2122 adjuvant in a single formulation.<\/p>\n<p>Session details are as follows:<\/p>\n<div>\n<table id=\"convertedTable855c\" cellspacing=\"0\" cellpadding=\"0\" border=\"0\" class=\"prntblns\">\n<tbody readability=\"7\">\n<tr readability=\"6\">\n<td class=\"prngen2\">\n<p class=\"prnews_p\"><span class=\"prnews_span\"><b>Date:<\/b><\/span><\/p>\n<\/td>\n<td class=\"prngen2\" readability=\"7\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">Wednesday, October 20, 2021<\/span><\/p>\n<\/td>\n<\/tr>\n<tr readability=\"4.5\">\n<td class=\"prngen2\">\n<p class=\"prnews_p\"><span class=\"prnews_span\"><b>Time:<\/b><\/span><\/p>\n<\/td>\n<td class=\"prngen2\" readability=\"6\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">11:30 a.m. \u2013 12:00 p.m. Central European Time (CET) \/ <br \/>5:30 a.m. \u2013 6:00 a.m. Eastern Daylight Time (EDT)<\/span><\/p>\n<\/td>\n<\/tr>\n<tr readability=\"3\">\n<td class=\"prngen2\">\n<p class=\"prnews_p\"><span class=\"prnews_span\"><b>Title:<\/b><\/span><\/p>\n<\/td>\n<td class=\"prngen2\" readability=\"5\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">Update on Novavax&#8217; NanoFlu vaccine and COVID-19-NanoFlu Combination Vaccine development<\/span><\/p>\n<\/td>\n<\/tr>\n<tr readability=\"7.5\">\n<td nowrap=\"nowrap\" class=\"prngen2\">\n<p class=\"prnews_p\"><span class=\"prnews_span\"><b>Novavax Participant:<\/b><\/span><\/p>\n<\/td>\n<td class=\"prngen2\" readability=\"8\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">Vivek Shinde, M.D., Vice President, Clinical Development<\/span><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table><\/div>\n<p>For more information or to register, visit the <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3325009-1&amp;h=3461158481&amp;u=https%3A%2F%2Fwww.terrapinn.com%2Fconference%2Fworld-vaccine-congress-europe%2Findex.stm&amp;a=Congress+website\" rel=\"nofollow noopener\">Congress website<\/a>. &nbsp;<\/p>\n<p><b>About Novavax<br \/><\/b>Novavax, Inc.&nbsp;(Nasdaq: NVAX) is a biotechnology company that promotes improved health globally through the discovery, development and commercialization of innovative vaccines to prevent serious infectious diseases. The company&#8217;s proprietary recombinant technology platform combines the power and speed of genetic engineering to efficiently produce highly immunogenic nanoparticles designed to address urgent global health needs.&nbsp;Novavax&nbsp;is conducting late-stage clinical trials for NVX-CoV2373, its vaccine candidate against SARS-CoV-2, the virus that causes COVID-19. NanoFlu\u2122, its quadrivalent influenza nanoparticle vaccine, met all primary objectives in its pivotal Phase 3 clinical trial in older adults. Both vaccine candidates incorporate&nbsp;Novavax&#8217; proprietary saponin-based Matrix-M\u2122 adjuvant to enhance the immune response and stimulate high levels of neutralizing antibodies. <\/p>\n<p>For more information, visit <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3325009-1&amp;h=2571408830&amp;u=http%3A%2F%2Fwww.novavax.com%2F&amp;a=www.novavax.com\" rel=\"nofollow noopener\">www.novavax.com<\/a> and connect with us on <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3325009-1&amp;h=2072522266&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D3158017-1%26h%3D500821283%26u%3Dhttps%253A%252F%252Ftwitter.com%252FNovavax%26a%3DTwitter&amp;a=Twitter\" rel=\"nofollow noopener\">Twitter<\/a> and <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3325009-1&amp;h=1813672409&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D3158017-1%26h%3D3702938248%26u%3Dhttps%253A%252F%252Fwww.linkedin.com%252Fcompany%252Fnovavax%252F%26a%3DLinkedIn&amp;a=LinkedIn\" rel=\"nofollow noopener\">LinkedIn<\/a>.<\/p>\n<p><b>Contacts:<\/b><\/p>\n<p><u>Investors<br \/><\/u>Novavax, Inc. <br \/><span class=\"xn-person\">Erika Schultz<\/span> | 240-268-2022<br \/><u><a target=\"_blank\" href=\"mailto:ir@novavax.com\" rel=\"nofollow noopener\">ir@novavax.com<\/a><\/u><\/p>\n<p>Solebury Trout<br \/><span class=\"xn-person\">Alexandra Roy<\/span> | 617-221-9197<br \/><u><a target=\"_blank\" href=\"mailto:aroy@soleburytrout.com\" rel=\"nofollow noopener\">aroy@soleburytrout.com<\/a><\/u><\/p>\n<p><u>Media<br \/><\/u><span class=\"xn-person\">Ali Chartan<\/span> | 240-720-7804<br \/><span class=\"xn-person\">Laura Keenan Lindsey<\/span> | 202-709-7521 <br \/><u><a target=\"_blank\" href=\"mailto:media@novavax.com\" rel=\"nofollow noopener\">media@novavax.com<\/a><\/u><\/p>\n<\/p><\/div>\n<p>Source: Novavax, Inc.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>GAITHERSBURG, Md., Oct. 16, 2021 \/PRNewswire\/ &#8212;&nbsp;Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that Vivek Shinde, M.D., Vice President, Clinical Development, will deliver a presentation during the World Vaccine Congress Europe 2021. A topic of discussion will be Novavax&#8217; COVID-NanoFlu\u2122 Combination Vaccine, [&hellip;]<\/p>\n","protected":false},"author":8,"featured_media":1621,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20],"tags":[],"class_list":["post-1620","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Novavax to Participate in World Vaccine Congress Europe - My Blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/transmediavictoria.net.au\/?p=1620\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Novavax to Participate in World Vaccine Congress Europe - My Blog\" \/>\n<meta property=\"og:description\" content=\"GAITHERSBURG, Md., Oct. 16, 2021 \/PRNewswire\/ &#8212;&nbsp;Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that Vivek Shinde, M.D., Vice President, Clinical Development, will deliver a presentation during the World Vaccine Congress Europe 2021. A topic of discussion will be Novavax&#8217; COVID-NanoFlu\u2122 Combination Vaccine, [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/transmediavictoria.net.au\/?p=1620\" \/>\n<meta property=\"og:site_name\" content=\"My Blog\" \/>\n<meta property=\"article:published_time\" content=\"2021-10-15T20:39:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/transmediavictoria.net.au\/wp-content\/uploads\/2021\/10\/novavax-to-participate-in-world-vaccine-congress-europe.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"599\" \/>\n\t<meta property=\"og:image:height\" content=\"264\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin_tony\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin_tony\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=1620#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=1620\"},\"author\":{\"name\":\"admin_tony\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\"},\"headline\":\"Novavax to Participate in World Vaccine Congress Europe\",\"datePublished\":\"2021-10-15T20:39:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=1620\"},\"wordCount\":310,\"image\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=1620#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/transmediavictoria.net.au\\\/wp-content\\\/uploads\\\/2021\\\/10\\\/novavax-to-participate-in-world-vaccine-congress-europe.jpg\",\"articleSection\":[\"Business News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=1620\",\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=1620\",\"name\":\"Novavax to Participate in World Vaccine Congress Europe - My Blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=1620#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=1620#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/transmediavictoria.net.au\\\/wp-content\\\/uploads\\\/2021\\\/10\\\/novavax-to-participate-in-world-vaccine-congress-europe.jpg\",\"datePublished\":\"2021-10-15T20:39:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=1620#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=1620\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=1620#primaryimage\",\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/wp-content\\\/uploads\\\/2021\\\/10\\\/novavax-to-participate-in-world-vaccine-congress-europe.jpg\",\"contentUrl\":\"https:\\\/\\\/transmediavictoria.net.au\\\/wp-content\\\/uploads\\\/2021\\\/10\\\/novavax-to-participate-in-world-vaccine-congress-europe.jpg\",\"width\":599,\"height\":264},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=1620#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/transmediavictoria.net.au\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Novavax to Participate in World Vaccine Congress Europe\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#website\",\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/\",\"name\":\"My Blog\",\"description\":\"My WordPress Blog\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\",\"name\":\"admin_tony\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"caption\":\"admin_tony\"},\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?author=8\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Novavax to Participate in World Vaccine Congress Europe - My Blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/transmediavictoria.net.au\/?p=1620","og_locale":"en_US","og_type":"article","og_title":"Novavax to Participate in World Vaccine Congress Europe - My Blog","og_description":"GAITHERSBURG, Md., Oct. 16, 2021 \/PRNewswire\/ &#8212;&nbsp;Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that Vivek Shinde, M.D., Vice President, Clinical Development, will deliver a presentation during the World Vaccine Congress Europe 2021. A topic of discussion will be Novavax&#8217; COVID-NanoFlu\u2122 Combination Vaccine, [&hellip;]","og_url":"https:\/\/transmediavictoria.net.au\/?p=1620","og_site_name":"My Blog","article_published_time":"2021-10-15T20:39:00+00:00","og_image":[{"width":599,"height":264,"url":"https:\/\/transmediavictoria.net.au\/wp-content\/uploads\/2021\/10\/novavax-to-participate-in-world-vaccine-congress-europe.jpg","type":"image\/jpeg"}],"author":"admin_tony","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin_tony","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/transmediavictoria.net.au\/?p=1620#article","isPartOf":{"@id":"https:\/\/transmediavictoria.net.au\/?p=1620"},"author":{"name":"admin_tony","@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7"},"headline":"Novavax to Participate in World Vaccine Congress Europe","datePublished":"2021-10-15T20:39:00+00:00","mainEntityOfPage":{"@id":"https:\/\/transmediavictoria.net.au\/?p=1620"},"wordCount":310,"image":{"@id":"https:\/\/transmediavictoria.net.au\/?p=1620#primaryimage"},"thumbnailUrl":"https:\/\/transmediavictoria.net.au\/wp-content\/uploads\/2021\/10\/novavax-to-participate-in-world-vaccine-congress-europe.jpg","articleSection":["Business News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/transmediavictoria.net.au\/?p=1620","url":"https:\/\/transmediavictoria.net.au\/?p=1620","name":"Novavax to Participate in World Vaccine Congress Europe - My Blog","isPartOf":{"@id":"https:\/\/transmediavictoria.net.au\/#website"},"primaryImageOfPage":{"@id":"https:\/\/transmediavictoria.net.au\/?p=1620#primaryimage"},"image":{"@id":"https:\/\/transmediavictoria.net.au\/?p=1620#primaryimage"},"thumbnailUrl":"https:\/\/transmediavictoria.net.au\/wp-content\/uploads\/2021\/10\/novavax-to-participate-in-world-vaccine-congress-europe.jpg","datePublished":"2021-10-15T20:39:00+00:00","author":{"@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7"},"breadcrumb":{"@id":"https:\/\/transmediavictoria.net.au\/?p=1620#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/transmediavictoria.net.au\/?p=1620"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/transmediavictoria.net.au\/?p=1620#primaryimage","url":"https:\/\/transmediavictoria.net.au\/wp-content\/uploads\/2021\/10\/novavax-to-participate-in-world-vaccine-congress-europe.jpg","contentUrl":"https:\/\/transmediavictoria.net.au\/wp-content\/uploads\/2021\/10\/novavax-to-participate-in-world-vaccine-congress-europe.jpg","width":599,"height":264},{"@type":"BreadcrumbList","@id":"https:\/\/transmediavictoria.net.au\/?p=1620#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/transmediavictoria.net.au\/"},{"@type":"ListItem","position":2,"name":"Novavax to Participate in World Vaccine Congress Europe"}]},{"@type":"WebSite","@id":"https:\/\/transmediavictoria.net.au\/#website","url":"https:\/\/transmediavictoria.net.au\/","name":"My Blog","description":"My WordPress Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/transmediavictoria.net.au\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7","name":"admin_tony","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","caption":"admin_tony"},"url":"https:\/\/transmediavictoria.net.au\/?author=8"}]}},"_links":{"self":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts\/1620","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1620"}],"version-history":[{"count":0,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts\/1620\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/media\/1621"}],"wp:attachment":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1620"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1620"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1620"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}